Clinical Trial Update: Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating interleukin-2 (Proleukin) for metastatic melanoma. The snippet lists a Phase 2 study with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Proleukin (aldesleukin)

Snippet

Sponsor: Blumenthal Cancer Center at Carolinas Medical Center | Conditions: Melanoma (Skin) | Phase 2 | Status: UNKNOWN